|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910786408003321 |
|
|
Autore |
Pradelli Lorenzo |
|
|
Titolo |
Pharmacoeconomics : principles and practice / / Lorenzo Pradelli, Albert Wertheimer |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Torino, Italy : , : SEEd, , 2012 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[First edition.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (125 p.) |
|
|
|
|
|
|
Soggetti |
|
Drugs - Cost effectiveness |
Pharmacy - Economic aspects |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
""Title Page""; ""Colophon ""; ""Table of Contents""; ""Preface""; ""Introduction""; ""Health Care Dilemma""; ""Opportunity Cost""; ""Efficiency and Equity""; ""Pharmacoeconomics""; ""Sensitivity Analysis""; ""Summary""; ""Further Readings""; ""1 Definitions and Basic Concepts""; ""1.1 Definitions""; ""1.2 Costs""; ""1.3 Consequences""; ""1.4 Perspectives""; ""1.5 Time Horizon""; ""2 Pharmacoeconomic Evaluations""; ""2.1 Introduction""; ""2.2 Cost Analysis""; ""2.3 Cost-outcomes Analysis""; ""2.4 Utility""; ""2.5 Psychometrics""; ""3 Modeling Frameworks""; ""3.1 Steps in Decision Analysis"" |
""3.2 Influence Diagrams""""3.3 Markov Models""; ""3.4 Discrete-event Simulation""; ""3.5 Agent-based Models""; ""4 Budget Impact Analysis""; ""4.1 Introduction""; ""4.2 Example: Budget Impact Analysis of Clinical Guidelines in COPD Patients""; ""5 Patient Reported Outcomes""; ""5.1 Introduction""; ""5.2 From Biological Measures to Patient Reported Outcome""; ""5.3 Quality of Life, Health Related Quality of Life, and Patient Reported Outcomes""; ""5.4 PRO Dimensions""; ""5.5 Every Patient has Individual Health Perceptions""; ""5.6 Applications of PRO Instruments"" |
""5.7 Identifying an Appropriate Instrument for Measuring PRO""""5.8 PRO Instruments""; ""5.9 When are the Results of PROs Relevant?""; ""5.10 Summary and Conclusion""; ""6 Data Sources and Accounting for Uncertainty""; ""6.1 Data Sources""; ""6.2 Statistical Analysis""; ""6.3 Accounting for Uncertainty""; ""6.4 Pharmacoeconomic Studies""; ""6.5 |
|
|
|
|